Nausea News and Research

RSS
Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.
Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

Salix Pharmaceuticals announces novel patient and health care provider support program for HE

Salix Pharmaceuticals announces novel patient and health care provider support program for HE

Nuvo Research's PENNSAID now available in U.S. pharmacies

Nuvo Research's PENNSAID now available in U.S. pharmacies

Court of Appeals denies McNeil Pediatrics' CONCERTA patent appeal

Court of Appeals denies McNeil Pediatrics' CONCERTA patent appeal

Aton Pharma acquires the U.S. marketing rights to LODOSYN tablets from BMS

Aton Pharma acquires the U.S. marketing rights to LODOSYN tablets from BMS

OSI Pharmaceuticals completes enrollment in Phase III clinical trial of Tarceva

OSI Pharmaceuticals completes enrollment in Phase III clinical trial of Tarceva

Covidien introduces PENNSAID to the U.S. market

Covidien introduces PENNSAID to the U.S. market

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

CAT may improve QOL in pediatric oncology patients undergoing therapy: Researchers

CAT may improve QOL in pediatric oncology patients undergoing therapy: Researchers

Victoza produces greater reductions in A1C, FPG and body weight than Januvia: Study

Victoza produces greater reductions in A1C, FPG and body weight than Januvia: Study

Drinking lemonade prevents kidney stone formation

Drinking lemonade prevents kidney stone formation

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Pfizer announces discontinuation of SUN 1170 Phase 3 study of Sutent in HCC

Pfizer announces discontinuation of SUN 1170 Phase 3 study of Sutent in HCC

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Columbia Laboratories' net revenues from US progesterone sales for first-quarter up 36%

Columbia Laboratories' net revenues from US progesterone sales for first-quarter up 36%

FDA approves Novartis Pharmaceuticals' Zortress for preventing rejection of kidney transplants

FDA approves Novartis Pharmaceuticals' Zortress for preventing rejection of kidney transplants

Merck to market and distribute MBL's Td vaccine in the U.S.

Merck to market and distribute MBL's Td vaccine in the U.S.

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Systems biologists integrate new genetic framework to help predict adverse drug reactions

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.